Vertex Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.

CEO

Reshma Kewalramani

CEOReshma Kewalramani

Employees

3,900

Employees3,900

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1989

Founded1989

Employees

3,900

Employees3,900

VRTX Key Statistics

Market cap

80.34B

Market cap80.34B

Price-Earnings ratio

24.70

Price-Earnings ratio24.70

Dividend yield

—

Dividend yield—

Average volume

1.23M

Average volume1.23M

High today

$317.03

High today$317.03

Low today

$312.02

Low today$312.02

Open price

$315.17

Open price$315.17

Volume

713.58K

Volume713.58K

52 Week high

$323.61

52 Week high$323.61

52 Week low

$182.66

52 Week low$182.66

VRTX News

Simply Wall St 2d

Are Robust Financials Driving The Recent Rally In Vertex Pharmaceuticals Incorporated's Stock?

Vertex Pharmaceuticals (NASDAQ:VRTX) has had a great run on the share market with its stock up by a significant 11% over the last three months. Given that the m...

Benzinga 3d

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,900 Today - Vertex Pharmaceuticals (N - Benzinga

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 12.09% on an annualized basis producing an average annual return of 23.11%. Cu...

Simply Wall St 6d

Vertex Pharmaceuticals Incorporated Shares Could Be 36% Below Their Intrinsic Value Estimate

Today we will run through one way of estimating the intrinsic value of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by projecting its future cash flows and...

Analyst ratings

64%

of 28 ratings

Buy

64.3%

Hold

35.7%

Sell

VRTX Earnings

$0.00

$1.34

$2.67

$4.01

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Jan 25, After Hours

ActualExpected Jan 25, After Hours